Specialist Working Group for Haematology Proposed changes to the Criteria for the clinical use of intravenous immunoglobulin in Australia, Second Edition ITEM CRITERIA FOR THE CLINICAL USE OF PROPOSED REVISIONS TO THE CRITERIA SWG RATIONALE FOR PROPOSED CHANGE INTRAVENOUS IMMUNOGLOBULIN IN (A) Administrative) AUSTRALIA, SECOND EDITION (CRITERIA) (B) Progressive (C) Programmed Condition Idiopathic (autoimmune) thrombocytopenic Immune thrombocytopenic purpura (ITP) in — Name purpura (ITP) in children 15 years and children 15 years and younger — younger Specialty Haematology Haematology Chapter 6 6 Specific SWG recommends tracking of Evan’s Syndrome Conditions within AIHA, ITP and ITP-Adult, rather than –child a stand alone condition. Evans syndrome Clear evidence of benefit (). Clear evidence of benefit (). Unchanged Level of Evidence
Specialist Working Group for Haematology Proposed changes to the Criteria for the clinical use of intravenous immunoglobulin in Australia, Second Edition ITEM CRITERIA FOR THE CLINICAL USE OF INTRAVENOUS IMMUNOGLOBULIN IN AUSTRALIA, SECOND EDITION (CRITERIA) PROPOSED REVISIONS TO THE CRITERIA SWG RATIONALE FOR PROPOSED CHANGE (A) Administrative) (B) Progressive (C) Programmed Condition Name Idiopathic (autoimmune) thrombocytopenic purpura (ITP) — in children 15 years and younger Immune thrombocytopenic purpura (ITP) — in children 15 years and younger Specialty Haematology Haematology Chapter 6 6 Specific Conditions Evans syndrome SWG recommends tracking of Evan’s Syndrome within AIHA, ITP –child and ITP-Adult, rather than a stand alone condition. Level of Evidence Clear evidence of benefit (). Clear evidence of benefit (). Unchanged
immune-thrombocytopenic-purpura-%28itp%29-in%20children%2015%20years%20and%20younger_0.DOCX